Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan;77(1):15-16.
doi: 10.1111/all.14995.

COVID-19 vaccines-The way forward

Affiliations
Editorial

COVID-19 vaccines-The way forward

Ludger Klimek et al. Allergy. 2022 Jan.
No abstract available

Keywords: COVID; SARS-CoV; virus.

PubMed Disclaimer

Conflict of interest statement

Dr. Klimek reports grants and/or personal fees from Allergopharma, MEDA/Mylan, HAL Allergie, ALK Abelló, LETI Pharma, Stallergenes, Quintiles, Sanofi, ASIT biotech, Lofarma, Allergy Therapeut., AstraZeneca, GSK, Inmunotk, Cassella med, outside the submitted work; and Membership: AeDA, DGHNO, Deutsche Akademie für Allergologie und klinische Immunologie, HNO‐BV, GPA, EAACI. Dr. Cooke reports to be a Member of the European Medicines Agency, Amsterdam, Netherlands. Dr. Jutel reports personal fees from ALK‐Abello, Allergopharma, Stallergenes, Anergis, Allergy Therapeutics, Leti, HAL, during the conduct of the study; personal fees from GSK, Novartis, Teva, Takeda, Chiesi, outside the submitted work. Dr. Akdis reports grants from Allergopharma, Idorsia, Swiss National Science Foundation, Christine Kühne‐Center for Allergy Research and Education, European Commission's Horison's 2020 Framework Programme, Cure, Novartis Research Institutes, Basel, Astra Zeneca, Switzerland, Scibase, Stockholm, advisory role for Sanofi/Regeneron, Glaxo Smith‐Kline, Novartis. Dr. Agache and Dr. O'Hehir have nothing to disclose.

References

    1. Simpson S, Chakrabarti A, Robinson D, Chirgwin K, Lumpkin M. Navigating facilitated regulatory pathways during a disease X pandemic. NPJ Vaccines. 2020;5:101. - PMC - PubMed
    1. Wagner R, Meißner J, Grabski E, Sun Y, Vieths S, Hildt E. Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe. Allergy. 2022. 10.1111/all.14868 - DOI - PMC - PubMed
    1. Eyes of the world are on medicines regulators . The race to produce COVID‐19 vaccines is a chance to create a more harmonized approvals process. Nature. 2020;588.
    1. COVID‐19 vaccines undergoing evaluation. 2021.
    1. Vaccine safety basics e‐learning course. 2021.

Publication types